BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 10506695)

  • 1. 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.
    Fata F; Ron IG; Kemeny N; O'Reilly E; Klimstra D; Kelsen DP
    Cancer; 1999 Oct; 86(7):1129-34. PubMed ID: 10506695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.
    Rodrigues D; de Souza T; Coyle L; Di Piazza M; Herpers B; Ferreira S; Zhang M; Vappiani J; Sévin DC; Gabor A; Lynch A; Chung SW; Saez-Rodriguez J; Jennen DGJ; Kleinjans JCS; de Kok TM
    Arch Toxicol; 2021 Aug; 95(8):2691-2718. PubMed ID: 34151400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
    Kimura Y; Okuda H
    Jpn J Cancer Res; 1999 Jul; 90(7):765-74. PubMed ID: 10470290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines.
    Sakai H; Sagara A; Matsumoto K; Hasegawa S; Sato K; Nishizaki M; Shoji T; Horie S; Nakagawa T; Tokuyama S; Narita M
    PLoS One; 2013; 8(1):e54788. PubMed ID: 23382968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-1 as an alternative treatment after 5-fluorouracil-induced coronary vasospasm in a patient with small bowel adenocarcinoma: a case report.
    Mitome N; Machida N; Shichiri Y; Kuwashima H; Murai A; Maeda S
    Int Cancer Conf J; 2024 Jan; 13(1):40-44. PubMed ID: 38187174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achyrocline B (3,5 dihydroxy-6,7,8-trimethoxyflavone) synergizes with 5-fluorouracil allowing for dose reduction and reduced off-target toxicity in the treatment of colonic and pancreatic cancers.
    Cartwright BM; Corso JN; Lightner J; Whitted C; Torrenegra RD; Krishnan K; Palau VE
    Biomed Pharmacother; 2023 Nov; 167():115546. PubMed ID: 37741250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamic model of the intestinal epithelium integrates multiple sources of preclinical data and enables clinical translation of drug-induced toxicity.
    Gall L; Jardi F; Lammens L; Piñero J; Souza TM; Rodrigues D; Jennen DGJ; de Kok TM; Coyle L; Chung SW; Ferreira S; Jo H; Beattie KA; Kelly C; Duckworth CA; Pritchard DM; Pin C
    CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1511-1528. PubMed ID: 37621010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids.
    Rodrigues D; van Kampen R; van Bodegraven AA; Kleinjans JCS; Jennen DGJ; de Kok TM
    Toxicol Lett; 2022 Dec; 371():17-24. PubMed ID: 36183961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "5-Fluorouracil-induced toxicity in both male and female reproductive systems: A narrative review".
    Hum Exp Toxicol; 2023; 42():9603271231224521. PubMed ID: 38147029
    [No Abstract]   [Full Text] [Related]  

  • 10. The Antitumor Potential of λ-Carrageenan Oligosaccharides on Gastric Carcinoma by Immunomodulation.
    Tang M; Zhai L; Chen J; Wang F; Chen H; Wu W
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Potential Role of Capsule Endoscopy in the Work-Up for Chemotherapy-Induced Diarrhea.
    Ando T; Sakumura M; Mihara H; Fujinami H; Yasuda I
    Healthcare (Basel); 2022 Jan; 10(2):. PubMed ID: 35206833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Emphysematous Gastritis Secondary to Chemotherapy.
    Ogbue OD; Haddad A; Daw H
    Cureus; 2021 Oct; 13(10):e18895. PubMed ID: 34804737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antarctic Strain of Rhodotorula mucilaginosa UFMGCB 18,377 Attenuates Mucositis Induced by 5-Fluorouracil in Mice.
    Coutinho JOPA; Quintanilha MF; Campos MRA; Ferreira E; de Menezes GCA; Rosa LH; Rosa CA; Vital KD; Fernandes SOA; Cardoso VN; Nicoli JR; Tiago FCP; Martins FS
    Probiotics Antimicrob Proteins; 2022 Jun; 14(3):486-500. PubMed ID: 34255281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea.
    Sakumura M; Ando T; Hosokawa A; Nakajima T; Motoo I; Mihara H; Ueda A; Kajiura S; Nanjo S; Fujinami H; Ogawa K; Yasuda I
    BMC Gastroenterol; 2020 Oct; 20(1):355. PubMed ID: 33109089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic perforation in a nasopharyngeal carcinoma patient treated with fluorouracil: A case report.
    Lu WJ; Li G; Gao L
    World J Clin Cases; 2020 May; 8(9):1693-1697. PubMed ID: 32420303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-treatment With BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction.
    McQuade RM; Al Thaalibi M; Petersen AC; Abalo R; Bornstein JC; Rybalka E; Nurgali K
    Front Neurosci; 2019; 13():449. PubMed ID: 31139044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity.
    Tawfik E; Ahamed M; Almalik A; Alfaqeeh M; Alshamsan A
    Saudi Pharm J; 2017 Feb; 25(2):206-213. PubMed ID: 28344470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling peptide nanofibers containing phenylalanine for the controlled release of 5-fluorouracil.
    Ashwanikumar N; Kumar NA; Saneesh Babu PS; Sivakumar KC; Vadakkan MV; Nair P; Hema Saranya I; Asha Nair S; Vinod Kumar GS
    Int J Nanomedicine; 2016; 11():5583-5594. PubMed ID: 27822037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
    Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
    Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.